MARINEMAX INC (HZO) Stock Fundamental Analysis

NYSE:HZO • US5679081084

31 USD
+2.49 (+8.73%)
At close: Feb 25, 2026
31.54 USD
+0.54 (+1.74%)
After Hours: 2/25/2026, 8:18:59 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall HZO gets a fundamental rating of 3 out of 10. We evaluated HZO against 123 industry peers in the Specialty Retail industry. HZO may be in some trouble as it scores bad on both profitability and health. HZO is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year HZO was profitable.
  • HZO had a positive operating cash flow in the past year.
  • Of the past 5 years HZO 4 years were profitable.
  • The reported operating cash flow has been mixed in the past 5 years: HZO reported negative operating cash flow in multiple years.
HZO Yearly Net Income VS EBIT VS OCF VS FCFHZO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • HZO's Return On Assets of -2.37% is on the low side compared to the rest of the industry. HZO is outperformed by 62.60% of its industry peers.
  • With a Return On Equity value of -6.18%, HZO perfoms like the industry average, outperforming 46.34% of the companies in the same industry.
  • HZO's Return On Invested Capital of 2.27% is in line compared to the rest of the industry. HZO outperforms 47.15% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for HZO is significantly below the industry average of 11.89%.
Industry RankSector Rank
ROA -2.37%
ROE -6.18%
ROIC 2.27%
ROA(3y)1.56%
ROA(5y)6.94%
ROE(3y)4.15%
ROE(5y)12.76%
ROIC(3y)4.73%
ROIC(5y)10.19%
HZO Yearly ROA, ROE, ROICHZO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

1.3 Margins

  • HZO has a Operating Margin of 2.94%. This is comparable to the rest of the industry: HZO outperforms 56.10% of its industry peers.
  • HZO's Operating Margin has declined in the last couple of years.
  • HZO has a Gross Margin of 31.59%. This is in the lower half of the industry: HZO underperforms 60.16% of its industry peers.
  • In the last couple of years the Gross Margin of HZO has grown nicely.
Industry RankSector Rank
OM 2.94%
PM (TTM) N/A
GM 31.59%
OM growth 3Y-27.03%
OM growth 5Y-9.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.37%
GM growth 5Y4.23%
HZO Yearly Profit, Operating, Gross MarginsHZO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HZO is destroying value.
  • The number of shares outstanding for HZO has been reduced compared to 1 year ago.
  • The number of shares outstanding for HZO remains at a similar level compared to 5 years ago.
  • HZO has a worse debt/assets ratio than last year.
HZO Yearly Shares OutstandingHZO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
HZO Yearly Total Debt VS Total AssetsHZO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 1.85 indicates that HZO is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • HZO has a Altman-Z score (1.85) which is in line with its industry peers.
  • The Debt to FCF ratio of HZO is 5.88, which is a neutral value as it means it would take HZO, 5.88 years of fcf income to pay off all of its debts.
  • HZO has a better Debt to FCF ratio (5.88) than 60.16% of its industry peers.
  • HZO has a Debt/Equity ratio of 1.13. This is a high value indicating a heavy dependency on external financing.
  • HZO has a Debt to Equity ratio of 1.13. This is comparable to the rest of the industry: HZO outperforms 41.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 5.88
Altman-Z 1.85
ROIC/WACC0.25
WACC9.07%
HZO Yearly LT Debt VS Equity VS FCFHZO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

2.3 Liquidity

  • HZO has a Current Ratio of 1.19. This is a normal value and indicates that HZO is financially healthy and should not expect problems in meeting its short term obligations.
  • HZO has a Current ratio of 1.19. This is comparable to the rest of the industry: HZO outperforms 40.65% of its industry peers.
  • HZO has a Quick Ratio of 1.19. This is a bad value and indicates that HZO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HZO's Quick ratio of 0.29 is on the low side compared to the rest of the industry. HZO is outperformed by 74.80% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.29
HZO Yearly Current Assets VS Current LiabilitesHZO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for HZO have decreased strongly by -77.62% in the last year.
  • HZO shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -24.26% yearly.
  • The Revenue has decreased by -1.10% in the past year.
  • The Revenue has been growing by 8.87% on average over the past years. This is quite good.
EPS 1Y (TTM)-77.62%
EPS 3Y-54.22%
EPS 5Y-24.26%
EPS Q2Q%-223.53%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y0.02%
Revenue growth 5Y8.87%
Sales Q2Q%7.84%

3.2 Future

  • HZO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.00% yearly.
  • HZO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.83% yearly.
EPS Next Y12.44%
EPS Next 2Y35.78%
EPS Next 3Y43%
EPS Next 5YN/A
Revenue Next Year2.85%
Revenue Next 2Y3.44%
Revenue Next 3Y3.83%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HZO Yearly Revenue VS EstimatesHZO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
HZO Yearly EPS VS EstimatesHZO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 65.96, the valuation of HZO can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as HZO.
  • When comparing the Price/Earnings ratio of HZO to the average of the S&P500 Index (27.05), we can say HZO is valued expensively.
  • With a Price/Forward Earnings ratio of 19.78, HZO is valued on the expensive side.
  • HZO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HZO is cheaper than 65.04% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of HZO to the average of the S&P500 Index (28.03), we can say HZO is valued slightly cheaper.
Industry RankSector Rank
PE 65.96
Fwd PE 19.78
HZO Price Earnings VS Forward Price EarningsHZO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HZO is valued a bit cheaper than 72.36% of the companies in the same industry.
  • HZO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HZO is cheaper than 95.94% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.7
EV/EBITDA 7.55
HZO Per share dataHZO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HZO does not grow enough to justify the current Price/Earnings ratio.
  • HZO's earnings are expected to grow with 43.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.3
PEG (5Y)N/A
EPS Next 2Y35.78%
EPS Next 3Y43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for HZO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MARINEMAX INC

NYSE:HZO (2/25/2026, 8:18:59 PM)

After market: 31.54 +0.54 (+1.74%)

31

+2.49 (+8.73%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners97.97%
Inst Owner Change-1.3%
Ins Owners2.85%
Ins Owner Change9.65%
Market Cap682.93M
Revenue(TTM)2.35B
Net Income(TTM)-57.62M
Analysts81.54
Price Target32.06 (3.42%)
Short Float %19.55%
Short Ratio10.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-81.02%
Min EPS beat(2)-230.66%
Max EPS beat(2)68.62%
EPS beat(4)2
Avg EPS beat(4)-34.43%
Min EPS beat(4)-230.66%
Max EPS beat(4)83.44%
EPS beat(8)4
Avg EPS beat(8)-4.44%
EPS beat(12)5
Avg EPS beat(12)-10.44%
EPS beat(16)8
Avg EPS beat(16)-4.53%
Revenue beat(2)2
Avg Revenue beat(2)2.95%
Min Revenue beat(2)2.61%
Max Revenue beat(2)3.28%
Revenue beat(4)3
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-12.47%
Max Revenue beat(4)8.06%
Revenue beat(8)4
Avg Revenue beat(8)-0.78%
Revenue beat(12)7
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)0.38%
PT rev (1m)1.85%
PT rev (3m)-4.35%
EPS NQ rev (1m)-47.86%
EPS NQ rev (3m)-73.08%
EPS NY rev (1m)6.17%
EPS NY rev (3m)-49.92%
Revenue NQ rev (1m)2.42%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)0.89%
Revenue NY rev (3m)-0.96%
Valuation
Industry RankSector Rank
PE 65.96
Fwd PE 19.78
P/S 0.29
P/FCF 3.7
P/OCF 2.9
P/B 0.73
P/tB 1.84
EV/EBITDA 7.55
EPS(TTM)0.47
EY1.52%
EPS(NY)1.57
Fwd EY5.06%
FCF(TTM)8.38
FCFY27.04%
OCF(TTM)10.7
OCFY34.52%
SpS106.49
BVpS42.34
TBVpS16.84
PEG (NY)5.3
PEG (5Y)N/A
Graham Number21.16
Profitability
Industry RankSector Rank
ROA -2.37%
ROE -6.18%
ROCE 4.7%
ROIC 2.27%
ROICexc 2.45%
ROICexgc 3.41%
OM 2.94%
PM (TTM) N/A
GM 31.59%
FCFM 7.87%
ROA(3y)1.56%
ROA(5y)6.94%
ROE(3y)4.15%
ROE(5y)12.76%
ROIC(3y)4.73%
ROIC(5y)10.19%
ROICexc(3y)5.21%
ROICexc(5y)12.96%
ROICexgc(3y)7.5%
ROICexgc(5y)19.19%
ROCE(3y)9.35%
ROCE(5y)16.79%
ROICexgc growth 3Y-45.93%
ROICexgc growth 5Y-23.4%
ROICexc growth 3Y-45.55%
ROICexc growth 5Y-25.45%
OM growth 3Y-27.03%
OM growth 5Y-9.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.37%
GM growth 5Y4.23%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 5.88
Debt/EBITDA 8.8
Cap/Depr 101.56%
Cap/Sales 2.18%
Interest Coverage 0.92
Cash Conversion 197.58%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.29
Altman-Z 1.85
F-Score5
WACC9.07%
ROIC/WACC0.25
Cap/Depr(3y)139.54%
Cap/Depr(5y)177.5%
Cap/Sales(3y)2.62%
Cap/Sales(5y)2.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.62%
EPS 3Y-54.22%
EPS 5Y-24.26%
EPS Q2Q%-223.53%
EPS Next Y12.44%
EPS Next 2Y35.78%
EPS Next 3Y43%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y0.02%
Revenue growth 5Y8.87%
Sales Q2Q%7.84%
Revenue Next Year2.85%
Revenue Next 2Y3.44%
Revenue Next 3Y3.83%
Revenue Next 5YN/A
EBIT growth 1Y-53.43%
EBIT growth 3Y-27.02%
EBIT growth 5Y-1%
EBIT Next Year20.82%
EBIT Next 3Y19.63%
EBIT Next 5YN/A
FCF growth 1Y182.68%
FCF growth 3Y-12.94%
FCF growth 5Y-47.23%
OCF growth 1Y252.08%
OCF growth 3Y-1.68%
OCF growth 5Y-24.9%

MARINEMAX INC / HZO FAQ

Can you provide the ChartMill fundamental rating for MARINEMAX INC?

ChartMill assigns a fundamental rating of 3 / 10 to HZO.


What is the valuation status of MARINEMAX INC (HZO) stock?

ChartMill assigns a valuation rating of 4 / 10 to MARINEMAX INC (HZO). This can be considered as Fairly Valued.


Can you provide the profitability details for MARINEMAX INC?

MARINEMAX INC (HZO) has a profitability rating of 3 / 10.


Can you provide the financial health for HZO stock?

The financial health rating of MARINEMAX INC (HZO) is 3 / 10.